For: | Woitas RP, Petersen U, Moshage D, Brackmann HH, Matz B, Sauerbruch T, Spengler U. HCV-specific cytokine induction in monocytes of patients with different outcomes of hepatitis C. World J Gastroenterol 2002; 8(3): 562-566 [PMID: 12046093 DOI: 10.3748/wjg.v8.i3.562] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v8/i3/562.htm |
Number | Citing Articles |
1 |
J. D. Rempel, K. B. Aborsangaya, M. P. Alphonse, G. Y. Minuk. The influence of North American Aboriginal ethnicity on pro‐inflammatory and anti‐inflammatory cytokine responses to IFN‐alpha. Journal of Viral Hepatitis 2009; 16(4): 292 doi: 10.1111/j.1365-2893.2008.01063.x
|
2 |
Tsung-Ting Tsai, Yi-Jui Chuang, Yee-Shin Lin, Shu-Wen Wan, Chia-Ling Chen, Chiou-Feng Lin. An emerging role for the anti-inflammatory cytokine interleukin-10 in dengue virus infection. Journal of Biomedical Science 2013; 20(1) doi: 10.1186/1423-0127-20-40
|
3 |
Yu Yang, Zheng-Kun Tu, Xing-Kai Liu, Ping Zhang. Mononuclear phagocyte system in hepatitis C virus infection. World Journal of Gastroenterology 2018; 24(44): 4962-4973 doi: 10.3748/wjg.v24.i44.4962
|
4 |
E. Schvoerer, M.C. Navas, C. Thumann, A. Fuchs, N. Meyer, F. Habersetzer, F. Stoll‐Keller. Production of interleukin‐18 and interleukin‐12 in patients suffering from chronic hepatitis C virus infection before antiviral therapy. Journal of Medical Virology 2003; 70(4): 588 doi: 10.1002/jmv.10434
|
5 |
Robert G. Schaut, Jodi L. McGill, John D. Neill, Julia F. Ridpath, Randy E. Sacco. Bovine viral diarrhea virus type 2 in vivo infection modulates TLR4 responsiveness in differentiated myeloid cells which is associated with decreased MyD88 expression. Virus Research 2015; 208: 44 doi: 10.1016/j.virusres.2015.05.017
|
6 |
Emil Chuang, Alfred Del Vecchio, Steve Smolinski, Xiao-Yu Song, Robert T. Sarisky. Biomedicines to reduce inflammation but not viral load in chronic HCV – what's the sense?. Trends in Biotechnology 2004; 22(10): 517 doi: 10.1016/j.tibtech.2004.08.011
|
7 |
Xue-Song Liang, Jian-Qi Lian, Yong-Xing Zhou, Qing-He Nie, Chun-Qiu Hao. A small yeast RNA inhibits HCV IRES mediated translation and inhibits replication of poliovirus <italic>in vivo</italic>. World Journal of Gastroenterology 2003; 9(5): 1008-1013 doi: 10.3748/wjg.v9.i5.1008
|
8 |
Laurissa Ouaguia, Olivier Morales, Dhafer Mrizak, Khaldoun Ghazal, Emmanuel Boleslawski, Claude Auriault, Véronique Pancré, Yvan de Launoit, Filoména Conti, Nadira Delhem. Overexpression of Regulatory T Cells Type 1 (Tr1) Specific Markers in a Patient with HCV-Induced Hepatocellular Carcinoma. ISRN Hepatology 2013; 2013: 1 doi: 10.1155/2013/928485
|
9 |
Fengwei Bai, Terrence Town, Feng Qian, Penghua Wang, Masahito Kamanaka, Tarah M. Connolly, David Gate, Ruth R. Montgomery, Richard A. Flavell, Erol Fikrig, Michael Gale. IL-10 Signaling Blockade Controls Murine West Nile Virus Infection. PLoS Pathogens 2009; 5(10): e1000610 doi: 10.1371/journal.ppat.1000610
|
10 |
Angela Dolganiuc, Shilpa Oak, Karen Kodys, Douglas T. Golenbock, Robert W. Finberg, Evelyn Kurt-Jones, Gyongyi Szabo. Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology 2004; 127(5): 1513 doi: 10.1053/j.gastro.2004.08.067
|
11 |
Mette Ejrnaes , Christophe M. Filippi , Marianne M. Martinic , Eleanor M. Ling , Lisa M. Togher , Shane Crotty , Matthias G. von Herrath . Resolution of a chronic viral infection after interleukin-10 receptor blockade . The Journal of Experimental Medicine 2006; 203(11): 2461 doi: 10.1084/jem.20061462
|
12 |
Bogna J. Świątek. Is interleukin-10 gene polymorphism a predictive marker in HCV infection?. Cytokine & Growth Factor Reviews 2012; 23(1-2): 47 doi: 10.1016/j.cytogfr.2012.01.005
|
13 |
Gabriella Par, Laszlo Szereday, Timea Berki, Laszlo Palinkas, Melinda Halasz, Attila Miseta, Geza Hegedus, Julia Szekeres-Bartho, Aron Vincze, Bela Hunyady, Alajos Par, Stephen J. Polyak. Increased Baseline Proinflammatory Cytokine Production in Chronic Hepatitis C Patients with Rapid Virological Response to Peginterferon Plus Ribavirin. PLoS ONE 2013; 8(7): e67770 doi: 10.1371/journal.pone.0067770
|
14 |
Jean-Christophe Beltra, Hélène Decaluwe. Cytokines and persistent viral infections. Cytokine 2016; 82: 4 doi: 10.1016/j.cyto.2016.02.006
|
15 |
CM Filippi, MG von Herrath. IL‐10 and the resolution of infections. The Journal of Pathology 2008; 214(2): 224 doi: 10.1002/path.2272
|
16 |
G Rasi, P Pierimarchi, P Sinibaldi Vallebona, F Colella, E Garaci. Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma. International Immunopharmacology 2003; 3(8): 1169 doi: 10.1016/S1567-5769(03)00012-2
|
17 |
Bijan Raziorrouh, Axel Ulsenheimer, Winfried Schraut, Malte Heeg, Peter Kurktschiev, Reinhart Zachoval, Maria–Christina Jung, Robert Thimme, Christoph Neumann–Haefelin, Sophia Horster, Martin Wächtler, Michael Spannagl, Jürgen Haas, Helmut M. Diepolder, Norbert H. Grüner. Inhibitory Molecules That Regulate Expansion and Restoration of HCV-Specific CD4+ T Cells in Patients With Chronic Infection. Gastroenterology 2011; 141(4): 1422 doi: 10.1053/j.gastro.2011.07.004
|
18 |
Limin Chen, Ivan Borozan, Jing Sun, Maha Guindi, Sandra Fischer, Jordan Feld, Nitasha Anand, Jenny Heathcote, Aled M. Edwards, Ian D. McGilvray. Cell-Type Specific Gene Expression Signature in Liver Underlies Response to Interferon Therapy in Chronic Hepatitis C Infection. Gastroenterology 2010; 138(3): 1123 doi: 10.1053/j.gastro.2009.10.046
|
19 |
Kamyar Kalantar-Zadeh, Loren G. Miller, Eric S. Daar. Diagnostic Discordance for Hepatitis C Virus Infection in Hemodialysis Patients. American Journal of Kidney Diseases 2005; 46(2): 290 doi: 10.1053/j.ajkd.2005.05.006
|
20 |
Tsung-Ting Tsai, Yi-Jui Chuang, Yee-Shin Lin, Chih-Peng Chang, Shu-Wen Wan, Sheng-Hsiang Lin, Chia-Ling Chen, Chiou-Feng Lin, Aravinda M. de Silva. Antibody-Dependent Enhancement Infection Facilitates Dengue Virus-Regulated Signaling of IL-10 Production in Monocytes. PLoS Neglected Tropical Diseases 2014; 8(11): e3320 doi: 10.1371/journal.pntd.0003320
|
21 |
Anatol Panasiuk, Danuta Prokopowicz, Bozena Panasiuk. Monocyte chemotactic protein-1 and soluble adhesion molecules as possible prognostic markers of the efficacy of antiviral treatment in chronic hepatitis C. World Journal of Gastroenterology 2004; 10(24): 3639-3642 doi: 10.3748/wjg.v10.i24.3639
|
22 |
Faria Ahmed, Andrea Ibrahim, Curtis L. Cooper, Ashok Kumar, Angela M. Crawley. Chronic Hepatitis C Virus Infection Impairs M1 Macrophage Differentiation and Contributes to CD8+ T-Cell Dysfunction. Cells 2019; 8(4): 374 doi: 10.3390/cells8040374
|
23 |
Sara Abouelasrar Salama, Muriel Lavie, Mieke De Buck, Jo Van Damme, Sofie Struyf. Cytokines and serum amyloid A in the pathogenesis of hepatitis C virus infection. Cytokine & Growth Factor Reviews 2019; 50: 29 doi: 10.1016/j.cytogfr.2019.10.006
|
24 |
G. Martin‐Blondel, A. Gales, J. Bernad, L. Cuzin, P. Delobel, K. Barange, J. Izopet, B. Pipy, L. Alric. Low interleukin‐10 production by monocytes of patients with a self‐limiting hepatitis C virus infection. Journal of Viral Hepatitis 2009; 16(7): 485 doi: 10.1111/j.1365-2893.2009.01094.x
|
25 |
Xue-Song Liang, Jian-Qi Lian, Yong-Xing Zhou, Mo-Bin Wan. Inhibitor RNA blocks the protein translation mediated by hepatitis C virus internal ribosome entry site <i>in vivo</i>. World Journal of Gastroenterology 2004; 10(5): 664-667 doi: 10.3748/wjg.v10.i5.664
|
26 |
Zhidong Zhang, Claudia Doel, John B. Bashiruddin. Interleukin-10 production at the early stage of infection with foot-and-mouth disease virus related to the likelihood of persistent infection in cattle. Veterinary Research 2015; 46(1) doi: 10.1186/s13567-015-0276-y
|
27 |
Xi-Mei Chen, Guo-Yu Chen, Zhi-Rong Wang, Feng-Shang Zhu, Xiao-Lei Wang, Xia Zhang. Detection of micrometastasis of gastric carcinoma in peripheral blood circulation. World Journal of Gastroenterology 2004; 10(6): 804-808 doi: 10.3748/wjg.v10.i6.804
|
28 |
A. L. French, C. T. Evans, D. M. Agniel, M. H. Cohen, M. Peters, A. L. Landay, S. N. Desai. Microbial Translocation and Liver Disease Progression in Women Coinfected With HIV and Hepatitis C Virus. Journal of Infectious Diseases 2013; 208(4): 679 doi: 10.1093/infdis/jit225
|
29 |
Wen-jing Zhang, Hua Wang, Qiao-xia Tong, Sheng-hua Jie, Dong-liang Yang, Cheng Peng. Involvement of TLR2-MyD88 in abnormal expression of miR-146a in peripheral blood monocytes of patients with chronic hepatitis C. Journal of Huazhong University of Science and Technology [Medical Sciences] 2015; 35(2): 219 doi: 10.1007/s11596-015-1414-5
|
30 |
Erika A. Eksioglu, Jennifer Bess, Graham Jones, Jennifer Dettloff, Parinda Dangmeon, Hui-Jia Dong, Haizhen Zhu, Roberto Firpi, Yiling Xu, David R. Nelson, Chen Liu. Characterization of Anti-HCV Antibodies in IL-10-Treated Patients. Viral Immunology 2010; 23(4): 359 doi: 10.1089/vim.2009.0095
|
31 |
Bogna Świątek-Kościelna, Ewelina Kałużna, Ewa Strauss, Danuta Januszkiewicz-Lewandowska, Iwona Bereszyńska, Jacek Wysocki, Jolanta Rembowska, Dominika Barcińska, Dariusz Antosik, Iwona Mozer-Lisewska, Jerzy Nowak. Interleukin 10 gene single nucleotide polymorphisms in Polish patients with chronic hepatitis C: Analysis of association with severity of disease and treatment outcome. Human Immunology 2017; 78(2): 192 doi: 10.1016/j.humimm.2016.10.015
|
32 |
Sang‐Jun Ha, Erin E. West, Koichi Araki, Kendall A. Smith, Rafi Ahmed. Manipulating both the inhibitory and stimulatory immune system towards the success of therapeutic vaccination against chronic viral infections. Immunological Reviews 2008; 223(1): 317 doi: 10.1111/j.1600-065X.2008.00638.x
|
33 |
Mathis Heydtmann. Macrophages in Hepatitis B and Hepatitis C Virus Infections. Journal of Virology 2009; 83(7): 2796 doi: 10.1128/JVI.00996-08
|
34 |
Aintzane Zabaleta, Delia D'Avola, Itziar Echeverria, Diana Llopiz, Leyre Silva, Lorea Villanueva, José Ignacio Riezu-Boj, Esther Larrea, Alexander Pereboev, Juan José Lasarte, Iago Rodriguez-Lago, Mercedes Iñarrairaegui, Bruno Sangro, Jesús Prieto, Pablo Sarobe. Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection. Molecular Therapy - Methods & Clinical Development 2015; 2: 15006 doi: 10.1038/mtm.2015.6
|
35 |
N. S. Yudin, A. V. Barkhash, V. N. Maksimov, E. V. Ignatieva, A. G. Romaschenko. Human Genetic Predisposition to Diseases Caused by Viruses from Flaviviridae Family. Molecular Biology 2018; 52(2): 165 doi: 10.1134/S0026893317050223
|
36 |
Radwa Saeed Elnahrawy, Sherif Aziz Zaki, Mona Wagdy Ayad, Mohamed Said Abdelsalam. Effect of direct-acting antiviral medications on α-fetoprotein, IL-10, and VEGF as predictors of HCC in HCV-infected hemodialysis patients. Journal of The Egyptian Society of Nephrology and Transplantation 2021; 21(2): 71 doi: 10.4103/jesnt.jesnt_22_20
|
37 |
Kamyar Kalantar-Zadeh, Eric S. Daar, Viktor E. Eysselein, Loren G. Miller. Hepatitis C inflection in dialysis patients: a link to poor clinical outcome?. International Urology and Nephrology 2007; 39(1) doi: 10.1007/s11255-006-9075-8
|
38 |
Cheng Peng, Hua Wang, Wen-Jing Zhang, Sheng-Hua Jie, Qiao-Xia Tong, Meng-Ji Lu, Dong-Liang Yang. Inhibitory effect of miR-125b on hepatitis C virus core protein-induced TLR2/MyD88 signaling in THP-1 cells. World Journal of Gastroenterology 2016; 22(17): 4354-4361 doi: 10.3748/wjg.v22.i17.4354
|
39 |
Jian Wang, Gui-Ju Xiang, Bing-Xiang Liu. Effect of alpha 2b interferon on inducement of mIL-2R and treatment of HCV in PBMC from patients with chronic viral hepatitis C. World Journal of Gastroenterology 2003; 9(4): 751-754 doi: 10.3748/wjg.v9.i4.751
|
40 |
Azhar Mehmood, Muhammad Javaid Asad, Muhammad Ovais, Nasib Zaman, Hafsa Aziz, Javaid Irfan, Irshad Ahmad, Abida Raza. The Absence of HCV RNA and NS5A Protein in Peripheral Blood Mononuclear Cells Is a Prognostic Tool for Sustained Virological Response. Viral Immunology 2017; 30(8): 568 doi: 10.1089/vim.2017.0030
|